0000000000938709

AUTHOR

Angela Criscimanna

showing 40 related works from this author

Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory

2011

Background Several epidemiological studies showed a close association between metabolic control and microvascular complications in type 1 Diabetes Mellitus (T1DM). The aim of our longitudinal observational study was to evaluate the predictive role of the main clinical and biochemical parameters in determining microvascular complications. Methods 376 T1DM patients, hospitalized in our division from 1991 to 2005 (mean follow-up = 10.93 ± 4.26 years) were studied. Stepwise Cox regression analysis was used to identify the influence of residual ß-cell function, ß-cell autoimmunity, HbA1c levels and other clinical and laboratory parameters in the development of microalbuminuria and retinopathy. R…

Malemedicine.medical_specialtyAdolescentendocrine system diseasesSettore MED/13 - EndocrinologiaNephropathyYoung AdultPredictive Value of TestsInsulin-Secreting CellsInternal medicineDiabetes mellitusInternal MedicinemedicineAlbuminuriaHumansDiabetic NephropathiesLongitudinal StudiesAge of OnsetChildAutoantibodiesProportional Hazards ModelsGlycated HemoglobinInpatientsType 1 diabetesDiabetic Retinopathybusiness.industryMicrocirculationMicroangiopathyType 1 diabetes microvascular Complicationsnutritional and metabolic diseasesmedicine.diseaseSurgeryDiabetes Mellitus Type 1Metabolic control analysisPredictive value of testsFemaleMicroalbuminuriaAge of onsetbusinessDiabetic AngiopathiesFollow-Up StudiesEuropean Journal of Internal Medicine
researchProduct

The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome

2007

BACKGROUND: Insulin glargine is a once-daily basal insulin analog with prolonged duration of action and absence of an evident peak. Glargine is associated with reduced frequency of hypoglycemic episodes (mostly nocturnal) as well as effective glycemic control. Maintenance of good metabolic control before conception and throughout pregnancy is essential to lower the risk of fetal malformations. Glargine might be a valuable alternative in the management of pregnancies complicated by diabetes mellitus. However, because its clinical utility has not been established, the use of glargine is not currently recommended during pregnancy. OBJECTIVE: The aim of this study was to retrospectively evaluat…

AdultHirsutismmedicine.medical_specialtyAdolescentendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentModels BiologicalSensitivity and SpecificitySettore MED/13 - EndocrinologiaYoung Adultchemistry.chemical_compoundEndocrinologyInternal medicineAcne VulgarismedicineHumansOutpatient clinicpcos insulin sensitivityRetrospective StudiesMetabolic SyndromeC-peptidebusiness.industryInsulinHyperandrogenismCase-control studynutritional and metabolic diseasesRetrospective cohort studymedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsOligomenorrheaEndocrinologychemistryCase-Control StudiesFemaleInsulin ResistanceMetabolic syndromeHyperandrogenismbusinessPolycystic Ovary SyndromeClinical Endocrinology
researchProduct

Recovery of Endogenous β-Cell Function in Nonhuman Primates After Chemical Diabetes Induction and Islet Transplantation

2008

OBJECTIVE—To describe the ability of nonhuman primate endocrine pancreata to reestablish endogenous insulin production after chemical β-cell destruction. RESEARCH DESIGN AND METHODS—Eleven monkeys (Macaca fascicularis) were rendered diabetic with streptozotocin. Eight diabetic monkeys received intraportal porcine islet transplantation. RESULTS—Two monkeys transplanted after 75 days of type 1 diabetes showed recovery of endogenous C-peptide production a few weeks after transplantation, concomitant with graft failure. Histological analysis of the pancreas of these monkeys showed insulin-positive cells, single or in small aggregates, scattered in the pancreas and adjacent to ducts. Interesting…

endocrine systemmedicine.medical_specialtySwineEndocrinology Diabetes and Metabolismmedicine.medical_treatmentIslets of Langerhans TransplantationBiologyStreptozocinDiabetes Mellitus ExperimentalInsulin-Secreting CellsInternal medicineDiabetes mellitusInternal MedicinemedicineAnimalsInsulinProinsulingeographyType 1 diabetesgeography.geographical_feature_categoryInsulinHaplorhiniStreptozotocinmedicine.diseaseIsletTransplantationmedicine.anatomical_structureEndocrinologyIslet StudiesPancreasmedicine.drugDiabetes
researchProduct

Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency

2007

Objective: GH replacement therapy in children with GH deficiency (GHD) mainly promotes linear growth. Not only have very few studies fully analyzed the metabolic consequences of GH therapy, but also the question as to whether GH may affect adipokine secretion has been insufficiently investigated. Our aim was to study the effects of GH replacement therapy on auxological data, lipid and glycemic profiles, insulin homeostasis (HOMA-IR) and serum adipokines in children. Methods: This was a 1-year prospective study. Thirty-four GHD children (11.6 ± 2.6 years) and thirty healthy matched controls were enrolled. Children affected by GHD were studied both before beginning continuous GH replacement t…

LeptinMalemedicine.medical_specialtyTime FactorsAdolescentHormone Replacement TherapyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentAdipokineBiologyBody Mass IndexSettore MED/13 - Endocrinologiachemistry.chemical_compoundEndocrinologyInternal medicinemedicineHumansInsulinInsulin-Like Growth Factor IChildGrowth DisordersTriglyceridesGlycemicmedicine.diagnostic_testAdiponectinHuman Growth HormoneCholesterolLeptinInsulinBody WeightCholesterol LDLGeneral MedicineBody HeightTreatment OutcomeEndocrinologychemistryTransgender hormone therapyFemaleAdiponectinLipid profileGH METABOLISM ADIPOKINESEuropean Journal of Endocrinology
researchProduct

In Vitro Generation of Pancreatic Endocrine Cells from Human Adult Fibroblast-Like Limbal Stem Cells

2012

Stem cells might provide unlimited supply of transplantable cells for β-cell replacement therapy in diabetes. The human limbus is a highly specialized region hosting a well-recognized population of epithelial stem cells, which sustain the continuous renewal of the cornea, and the recently identified stromal fibroblast-like stem cells (f-LSCs), with apparent broader plasticity. However, the lack of specific molecular markers for the identification of the multipotent limbal subpopulation has so far limited the investigation of their differentiation potential. In this study we show that the human limbus contains uncommitted cells that could be potentially harnessed for the treatment of diabete…

Pluripotent Stem CellsStromal cellCellular differentiationPopulationBiomedical Engineeringlcsh:MedicineEnteroendocrine cellLimbus CorneaeBiologyLimbus; β-CellsSettore MED/13 - EndocrinologiaLimbuInsulin-Secreting CellsInsulin SecretionDiabetes MellitusHumansInsulineducationInduced pluripotent stem cellCells CulturedProinsulinTransplantationeducation.field_of_studyDiabeteslcsh:RCell DifferentiationCell Biologyβ-CellsCell biologyAdult Stem CellsStem cellFibroblast-like stem cellsBiomarkersAdult stem cellCell Transplantation
researchProduct

BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.

2011

BRAFV600E is the most common mutation found in papillary thyroid carcinoma (PTC). Tissue inhibitor of metalloproteinases (TIMP-1) and nuclear factor (NF)-κB have been shown to play an important role in thyroid cancer. In particular, TIMP-1 binds its receptor CD63 on cell surface membrane and activates Akt signaling pathway, which is eventually responsible for its anti-apoptotic activity. The aim of our study was to evaluate whether interplay among these three factors exists and exerts a functional role in PTCs. To this purpose, 56 PTC specimens were analyzed for BRAFV600E mutation, TIMP-1 expression, and NF-κB activation. We found that BRAFV600E mutation occurs selectively in PTC nodules an…

MAPK/ERK pathwayAdultMaleProto-Oncogene Proteins B-rafCancer Researchmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismThyroid cancer TIMP-1 papillary thyroid cancerMutation MissenseGlutamic AcidGene Expression Regulation EnzymologicSettore MED/13 - EndocrinologiaPapillary thyroid cancerEndocrinologyDownregulation and upregulationInternal medicinemedicineTumor Cells CulturedGene silencingHumansGene Regulatory NetworksNeoplasm InvasivenessThyroid NeoplasmsProtein kinase BThyroid cancerTissue Inhibitor of Metalloproteinase-1ChemistryAkt/PKB signaling pathwayCarcinomaNF-kappa BValineMiddle Agedmedicine.diseaseCarcinoma PapillaryUp-RegulationGene Expression Regulation NeoplasticEndocrinologyCell Transformation NeoplasticOncologyAmino Acid SubstitutionThyroid Cancer PapillaryCancer researchDisease ProgressionFemaleV600ESignal TransductionEndocrine-related cancer
researchProduct

In Vitro Phenotypic, Genomic and Proteomic Characterization of a Cytokine-Resistant Murine β-TC3 Cell Line

2012

Type 1 diabetes mellitus (T1DM) is caused by the selective destruction of insulin-producing β-cells. This process is mediated by cells of the immune system through release of nitric oxide, free radicals and pro-inflammatory cytokines, which induce a complex network of intracellular signalling cascades, eventually affecting the expression of genes involved in β-cell survival. The aim of our study was to investigate possible mechanisms of resistance to cytokine-induced β-cell death. To this purpose, we created a cytokine-resistant β-cell line (β-TC3R) by chronically treating the β-TC3 murine insulinoma cell line with IL-1β + IFN-γ. β-TC3R cells exhibited higher proliferation rate and resistan…

ProteomicsAnatomy and Physiologymedicine.medical_treatmentCell Culture Techniqueslcsh:MedicineApoptosisSettore MED/13 - EndocrinologiaMiceEndocrinologyImmune PhysiologyInsulin-Secreting CellsMolecular Cell BiologySOCS3lcsh:ScienceMultidisciplinaryCell DeathDiabetes mellitus cytokines. apoptosis SUMO4 NF-kBCell CycleNF-kappa BGenomicsCell cycleImmunohistochemistryCell biologyPhenotypeCytokineMedicineCytokinesResearch ArticleProgrammed cell deathCell SurvivalImmunologyDown-RegulationBiologyAutoimmune DiseasesCell LineDownregulation and upregulationmedicineAnimalsGene SilencingBiologyCell ProliferationDiabetic EndocrinologyEndocrine PhysiologyCell growthlcsh:RCell cultureApoptosisImmune SystemClinical ImmunologyInsulinomalcsh:QPLoS ONE
researchProduct

Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome

2006

Objective: It is well known that hyperandrogenism and insulin-resistance with or without compensatory hyperinsulinism are closely associated, but the Rotterdam Consensus has concluded that principally obese women with polycystic ovary syndrome (PCOS) should be evaluated for the metabolic syndrome. Our aim was to study insulin sensitivity in PCOS women with hirsutism regardless of obesity. Methods: Clinical characteristics, sex hormones and fasting- and after OGTT-glycemia and insulinemia, homeostatic model of insulin resistance (HOMA IR), and Matsuda index of insulin sensitivity were analyzed in 130 women with PCOS. Hirsutism has been evaluated through the Ferriman–Gallwey (FG) map scoring …

Adultmedicine.medical_specialtyHirsutismAdolescentEndocrinology Diabetes and Metabolismmedicine.medical_treatmentSettore MED/13 - EndocrinologiaDiagnosis DifferentialEndocrinologyInsulin resistanceInternal medicineHyperinsulinismmedicineHumansTestosteroneObesitySicilyhirsutismMetabolic Syndromebusiness.industryDehydroepiandrosterone SulfateInsulinHyperandrogenismAndrostenedioneGeneral Medicinemedicine.diseasePolycystic ovaryEndocrinologyPCOS INSULIN RESISTANCE HIRSUTISMFemaleMetabolic syndromeInsulin ResistancebusinessHyperandrogenismHyperinsulinismBody mass indexPolycystic Ovary Syndrome
researchProduct

In Vitro Identification and Characterization of CD133pos Cancer Stem-Like Cells in Anaplastic Thyroid Carcinoma Cell Lines

2008

BackgroundRecent publications suggest that neoplastic initiation and growth are dependent on a small subset of cells, termed cancer stem cells (CSCs). Anaplastic Thyroid Carcinoma (ATC) is a very aggressive solid tumor with poor prognosis, characterized by high dedifferentiation. The existence of CSCs might account for the heterogeneity of ATC lesions. CD133 has been identified as a stem cell marker for normal and cancerous tissues, although its biological function remains unknown.Methodology/principal findingsATC cell lines ARO, KAT-4, KAT-18 and FRO were analyzed for CD133 expression. Flow cytometry showed CD133(pos) cells only in ARO and KAT-4 (64+/-9% and 57+/-12%, respectively). These …

Pathologymedicine.medical_specialtySciencemedicine.medical_treatmentThyroid Nuclear Factor 1Cell Culture TechniquesAntineoplastic AgentsCell SeparationStem cell markerDiabetes and Endocrinology/ThyroidSettore MED/13 - EndocrinologiaAntigens CDThyroid peroxidaseCancer stem cellCell Line TumorBiomarkers TumormedicineHumansANAPLASTIC THYROID CARCINOMA CANCER STEM CELLS CD133AC133 AntigenThyroid NeoplasmsGenetics and Genomics/Cancer GeneticsThyroid cancerTumor Stem Cell AssayCell ProliferationGlycoproteinsOncology/Head and Neck CancersMultidisciplinarybiologyCell growthQCarcinomaRNuclear ProteinsTumor Stem Cell Assaymedicine.diseaseFibronectinsembryonic structuresNeoplastic Stem CellsCancer researchbiology.proteinMedicineThyroglobulinStem cellPeptidesTranscription FactorsResearch ArticlePLoS ONE
researchProduct

Visceral Adiposity Index

2010

OBJECTIVE To individuate a novel sex-specific index, based on waist circumference, BMI, triglycerides, and HDL cholesterol, indirectly expressing visceral fat function. RESEARCH DESIGN AND METHODS Visceral adiposity index (VAI) was first modeled on 315 nonobese healthy subjects. Using two multiple logistic regression models, VAI was retrospectively validated in 1,498 primary care patients in comparison to classical cardio- and cerebrovascular risk factors. RESULTS All components of metabolic syndrome increased significantly across VAI quintiles. VAI was independently associated with both cardiovascular (odd ratio [OR] 2.45; 95% CI 1.52–3.95; P < 0.001) and cerebrovascular (1.63; 1.0…

AdultMaleCardiovascular and Metabolic Riskmedicine.medical_specialtyWaistEndocrinology Diabetes and MetabolismAdipose tissueIntra-Abdominal FatLogistic regressionBody Mass IndexYoung Adultchemistry.chemical_compoundRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineHumansTriglyceridesOriginal ResearchAgedAged 80 and overAdvanced and Specialized Nursingbusiness.industryCholesterolCholesterol HDLMiddle Agedmedicine.diseaseLogistic ModelsEndocrinologychemistryCardiovascular DiseasesCardiologyFemaleWaist CircumferenceMetabolic syndromebusinessBody mass indexLipid Accumulation ProductDiabetes Care
researchProduct

Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.

2008

BACKGROUND: Insulin glargine is a once-daily basal insulin analog with prolonged duration of action and absence of an evident peak. Glargine is associated with reduced frequency of hypoglycemic episodes (mostly nocturnal) as well as effective glycemic control. Maintenance of good metabolic control before conception and throughout pregnancy is essential to lower the risk of fetal malformations. Glargine might be a valuable alternative in the management of pregnancies complicated by diabetes mellitus. However, because its clinical utility has not been established, the use of glargine is not currently recommended during pregnancy. OBJECTIVE: The aim of this study was to retrospectively evaluat…

AdultBlood Glucosemedicine.medical_specialtyInsulin IsophanePregnancy in DiabeticsInsulin GlargineSettore MED/13 - EndocrinologiaInsulin aspartPregnancyDiabetes mellitusInternal medicinemedicineOutpatient clinicInsulin lisproHumansHypoglycemic AgentsInsulinPharmacology (medical)Body Weights and MeasuresFemurInsulin AspartGlycemicRetrospective StudiesPharmacologyGlycated HemoglobinType 1 diabetesPregnancyInsulin LisproInsulin glarginebusiness.industryglargine type 1 diabetesPregnancy Outcomemedicine.diseaseInsulin Long-ActingEndocrinologyDiabetes Mellitus Type 1Case-Control StudiesFemalebusinessmedicine.drugClinical therapeutics
researchProduct

Relative Hypoleptinemia in poor controlled patients with Type 1 Diabetes

2007

AdultBlood GlucoseLeptinMalemedicine.medical_specialtyTYPE 1 DIABETES HYPOLEPTINEMIAEndocrinology Diabetes and MetabolismClinical BiochemistryBlood PressureFatty Acids NonesterifiedBiochemistryBody Mass IndexSettore MED/13 - EndocrinologiaEndocrinologyInternal medicineMedicineHumansProspective StudiesGlycated HemoglobinType 1 diabetesbusiness.industryBiochemistry (medical)General Medicinemedicine.diseaseCholesterolDiabetes Mellitus Type 1FemaleInsulin Resistancebusiness
researchProduct

Difficoltà di identificazione della sindrome MEN2B ad esordio infantile: iter diagnostico.

2004

MEN2B syndromeSettore MED/13 - Endocrinologia
researchProduct

Th1 and Th2 cell phenotypes in AITD: role of allergy in Graves' disease

2004

GRAVES' DISEASE CYTOKINES ALLERGYSettore MED/13 - Endocrinologia
researchProduct

Distinct subsets of intrathyroidal regulatory CD4+CD25+ and CD8+CD25+ T cells in Hashimoto's thyroiditis: Potential role in the neoplastic cell growt…

2005

Tregs T regulatory cells hashimoto's thyroiditisSettore MED/13 - Endocrinologia
researchProduct

L’espressione di citochine TH1 e TH2 nei pazienti affetti da tireopatia autoimmune (AITD) e diabete di tipo 1

2004

TIROIDITE CRONICA AUTOIMMUNE DIABETE MELLITO TIPO 1 CITOCHINESettore MED/13 - Endocrinologia
researchProduct

High expression of peroxisome proliferator-activated receptor gamma (PPRgamma) in infiltrating lymphocytes from glands with Hashimoto's thyroiditis.

2005

PPARgamma Hashimoto's thyroiditisSettore MED/13 - Endocrinologia
researchProduct

L’uso del hrTSH nel follow up del microcarcinoma tiroideo in pazienti sottoposti a tiroidectomia totale

2004

CARCINOMA DELLA TIROIDE hrTSHSettore MED/13 - Endocrinologia
researchProduct

Changes in lipid profile and adipokine levels in GH deficient children during GH replacement therapy.

2006

GH growth hormone adipokineSettore MED/13 - Endocrinologia
researchProduct

Detection of BRAFv600E mutation in papillary thyroid carcinoma using real time allele-specific amplification on fine needle aspiration biopsy specime…

2006

BRAF papillary thyroid carcinomaSettore MED/13 - Endocrinologia
researchProduct

Ruolo della terapia medica nel Morbo di Basedow.

2004

Autoimmune Thyroid Disease Graves' DiseaseSettore MED/13 - Endocrinologia
researchProduct

Limbal stem cells as a potential source of pancreatic beta cells

2009

BACKGROUND/RATIONAL Beta cell replacement therapy represents an alternative approach to conventional insulin regimen for the management of type 1 diabetes. Stem cells theoretically represent a suitable and renewable source of surrogate beta cells. Recently, it has been demonstrated that corneal epithelium contains stem cells in the basal layer of the limbus. Our aim was to isolate and characterize limbal stem cells (LSCs) from adult corneal-limbal biopsies, and to assess their capability to differentiate into insulin-producing cells. METHODS 2-3 mm2 biopsies were obtained from limbus and central cornea of four patients undergoing surgery for ocular diseases not involving conjuctive or corne…

Endocrinologia Metabolismo e NutrizioneRicerca e sviluppo sperimentale nel campo delle biotecnologieSettore MED/13 - Endocrinologia
researchProduct

Leptina e adiponectina nella valutazione del compenso glicometabolico in corso di diabete mellito di tipo 1 normopeso.

2006

leptina adiponectina diabete tipo 1Settore MED/13 - Endocrinologia
researchProduct

Caratterizzazione proteomica di una linea beta cellulare resistente all'effetto citochinico

2012

SUMO apoptosis beta cellule diabeteSettore MED/46 - Scienze Tecniche Di Medicina Di LaboratorioSettore MED/13 - Endocrinologia
researchProduct

Iter diagnostico "rapido" per un caso di MEN IIb in un giovane adolescente

2004

MEN IIB CARCINOMA MIDOLLARE DELLA TIROIDE FEOCROMOCITOMA GENE RETSettore MED/13 - Endocrinologia
researchProduct

Cellule Staminali Pancreatiche

2004

non disponibile

diabete cellule staminali pancreaticheSettore MED/13 - Endocrinologia
researchProduct

Rotterdam consensus, NIH and EAS: comparison among the three different diagnostic criteria for the diagnosis of PCOS.

2007

PCOSSettore MED/13 - Endocrinologia
researchProduct

Different Th1/Th2 cytokine expression in Type 1 diabetes mellitus patients (T1DM) alone or associated with autoimmune thyroid disease (AITD)

2004

TYPE 1 DIABETES AUTOIMMUNE THYROID DISEASE CYTOKINESettore MED/13 - Endocrinologia
researchProduct

Visceral Adiposity Index (VAI): A Reliable Indicator Of Visceral Fat Function Associated With Cardiometabolic Risk.

2010

Objective: To individuate a novel sex-specific index, based on Waist Circumference (WC), Body Mass Index (BMI), Triglycerides (TG) and HDL cholesterol (HDL), indirectly expressing visceral fat function. Research design and Methods: Visceral Adiposity Index (VAI) was first modelled on 315 non-obese healthy subjects. Using two multiple logistic regression models, VAI was retrospectively validated in 1,498 primary care patients in comparison to classical cardio and cerebrovascular risk factors. Results: All components of metabolic syndrome increased significantly across VAI quintiles. VAI was independently associated with both cardiovascular (OR:2.45; 95%CI: 1.52-3.95; p<0.001) and cerebrov…

Visceral Adiposity IndexCardiometabolic Risk
researchProduct

BrafV600E mutation and hyperexpression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in papillary thyroid carcinoma

2009

Settore MED/06 - Oncologia MedicaTimp-1 braf thyroid carcinomaSettore MED/13 - Endocrinologia
researchProduct

Recovery of endogenous beta cell function in non-human primates following chemical diabetes induction and islet transplantation

2009

Objectives: To describe the ability of non-human primate endocrine pancreata to re-establish endogenous insulin production after chemical beta cell destruction. Research Design and Methods: Eleven monkeys (macaca fascicularis) were rendered diabetic with streptozotocin. Eight diabetic monkeys received intraportal porcine islet transplantation. Results: Two monkeys transplanted after 75 days of insulin dependent diabetes, showed recovery of endogenous C-peptide production a few weeks after transplantation, concomitant with graft failure. Histological analysis of the pancreas of these monkeys showed insulin-positive cells, single or in small aggregates scattered in the pancreas and adjacent t…

DIABETES BETA CELL REGENERATION ISLET TRANSPLANTATION NON-HUMAN PRIMATESSettore MED/13 - Endocrinologia
researchProduct

La terapia sostitutiva cellulare per la cura del diabete mellito: utilizzo di cellule staminali adulte, rigenerazione β-cellulare endogena, o entramb…

2012

adultediabete mellitoβ-cellulare endogencellule staminaliterapiaSettore MED/13 - Endocrinologia
researchProduct

Stem cell replacement therapy in type 1 diabetes

2007

Type 1 diabetes is caused by the autoimmune destruction of pancreatic insulin-producing beta cells and most frequently occurs in genetically susceptible children. Due to beta cell loss, Type 1 diabetes is an ideal candidate for cell replacement therapy. Replacement could be achieved via whole pancreas or isolated islet transplantation, but, at present, feasibility of these procedures is severely limited by the shortage of donor pancreata. Stem cells, characterized by their high potential for self-renewal and the simultaneous ability to differentiate into a desired cytotype, theoretically represent a suitable and renewable source of surrogate beta cells. However, despite many promising resul…

TYPE 1 DIABETES BETA CELL REPLACEMENT THERAPYSettore MED/13 - Endocrinologia
researchProduct

Decremento delle cellule T regolatorie (Treg) CD4+CD25+FOXP3+ nei linfociti periferici dei pazienti affetti da diabete di tipo 1.

2006

Treg cellule T regolatorie diabete tipo 1Settore MED/13 - Endocrinologia
researchProduct

Differential protein expression in cytokine-sensitive and -resistant pancreatic beta cell lines

2009

beta cells pancreas proteomicscytokineSettore BIO/06 - Anatomia Comparata E CitologiaSettore MED/13 - Endocrinologia
researchProduct

Apoptosis in Thyroid Autoimunity.

2007

Thyroid Autoimmunity ApoptosisSettore MED/13 - Endocrinologia
researchProduct

Low hrTSH-Tg levels in patients affected by papillary thyroid microcarcinoma are influenced by pre-surgery L-thyroxine therapy.

2006

Tireoglobulin tg papillary carcinoma thyroidSettore MED/13 - Endocrinologia
researchProduct

Amplificazione real-time allele-specifica per l'individuazione della mutazione V600E del B-RAF nel carcinoma papillare su agoaspirato tiroideo.

2005

BRAF carcinoma papillare tiroideSettore MED/13 - Endocrinologia
researchProduct

Differente pattern di espressione di citochine a fenotipo Th1 e Th2 nei pazienti affetti da diabete di tipo 1 (T1DM) e con associata tireopatia autoi…

2004

DIABETE MELLITO TIPO 1 TIROIDITE CRONICA AUTOIMMUNE CITOCHINESettore MED/13 - Endocrinologia
researchProduct

L’espressione del “peroxisome proliferator-activated gamma” (PPARgamma) nelle tireopatie croniche autoimmuni

2003

PPPARgamma TIROIDITE CRONICA AUTOIMMUNESettore MED/13 - Endocrinologia
researchProduct